Pharma TechOct 30, 2026
IDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19
At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III SCORPIO-PEP trial.
Read MorePharmaVoice Blog
Pharma TechOct 30, 2026
At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III SCORPIO-PEP trial.
Read More
Pharma TechOct 30, 2026
At IDWeek 2026, Samir K Gupta presented a pooled analysis of the Phase III ISLEND-1 and ISLEND-2 trials evaluating once-weekly ISL/LEN in adults with virologically suppressed HIV.
Read More
Pharma TechOct 30, 2026
Legal experts say that pharma outcome bets on platforms like Kalshi and Polymarket pose new insider trading risks.
Read More
PharmaShotsOct 30, 2026
Shots: Note: Ranks and companies are shown with FY2025 revenue of the qualifying skin care, dermocosmetics, sun care or aesthetics line in USD M, converted at 31 December 2025 exchange rates. Growth for every company is shown below. 20. Bloomage Biotech Skin Segment Revenue: $0.35B Qualifying Line: Skin science innovation (functional skincare) and skin-type medical… The post Top 20 Skincare and Dermocosmetics Companies of 2026 appeared first on PharmaShots.
Read More
Pharma TechOct 30, 2026
Following this MHRA label expansion, UK patients with β-thalassemia and sickle cell disease aged five and up can now receive Casgevy.
Read More
Pharma TechOct 30, 2026
Sales for Eli Lilly’s Mounjaro and Zepbound topped $16bn, exceeding total revenue for many big pharma players.
Read MoreSponsored Content

Sponsored
Purchase All Medicines.Get 10% Offer